How Facebook’s Demographic Targeting Changes Affect Clinical Trial Marketing
Starting this fall, Facebook will no longer allow advertisers to target based on racial and ethnic identifiers. Here’s what that means for clinical trials looking to recruit a racially diverse group of patients.
Why Age Diversity Matters in Clinical Trials
Too many clinical trials exclude older patients because of difficult recruitment processes or comorbid conditions. But digital marketing can help round out this critical patient segment.
Minority Patients Underrepresented in Clinical Trials – But They Want to Participate
Effective clinical trials rely on diverse patient populations. So why are minority participants consistently underrepresented?
New Study Reveals Reason for Lack of Minority Participation in Clinical Trials
What’s the largest barrier to clinical trial participation for minority patients? You might be surprised.
FDA Releases New Clinical Trial Diversity Data
Patient diversity in clinical trials is improving slowly – here’s one solution that might help speed things up.
Patient Diversity in Clinical Trials: How Technology Can Make a Difference
Ethnic and racial diversity in clinical research is still a massive issue, and sponsors and CROs need to seek out more scalable, cost-effective solutions.
Bolstering Diversity in Clinical Trials
Clinical trials have a diversity problem, and it could be having a negative impact on their ability to secure FDA approval. Here’s what you need to know.
